Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric subjects with secondary hyperparathyroidism receiving hemodialysis

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2019
This article has no abstract
Epistemonikos ID: e322628a8d49b04a16e541ff207e982b02cd34dc
First added on: Feb 12, 2025